OrbiMed Israel GP II, L.P., Director, 10% Owner at LogicBio Therapeutics, Inc. (LOGC), bought 4,187,760 shares at $10.00 ($11.9M) on 2018-10-23, disclosed to the SEC on 2018-10-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,997,760 | $0 | 0.0% |
| 2 | $10.00 | 490,000 | $4.9M | 41.2% |
| 3 | $10.00 | 700,000 | $7.0M | 58.8% |
| Total | $2.84 avg | 4,187,760 | $11.9M | 100% |
| Filing → |